Related Experiment Videos
[Characteristics of therapy of heart diseases in old age]
1Carl-Korth-Institut für poliklinische Medizin, Abteilung für medizinische Interventionsgerontologie Erlangen.
Insights
Diagnosing and treating cardiac conditions like heart failure, coronary heart disease, and arrhythmia in older adults is complex due to combined conditions and age-related physiological changes, increasing interaction risks.
Area of Science:
- Geriatric Medicine
- Cardiology
- Clinical Pharmacology
Context:
- Cardiac insufficiency, coronary heart disease, and arrhythmia are highly prevalent and often comorbid in elderly patients.
- Elderly patients present unique physiological and pathophysiological conditions complicating cardiac disease diagnosis.
- Multimorbidity in the elderly necessitates careful consideration of polypharmacy and potential drug interactions.
Purpose:
- To highlight the diagnostic challenges of cardiac diseases in the elderly.
- To discuss modifications required for effective cardiac disease therapy in advanced age.
- To underscore the increased risk of drug interactions in elderly patients with multiple health conditions.
Summary:
- Cardiac diseases are more frequent and often combined in older individuals.
- Diagnosis and treatment are complicated by age-related physiological changes and general morbidity.
- Pharmacodynamic and pharmacokinetic alterations in the elderly, coupled with multimorbidity, elevate the risk of drug interactions.
Impact:
- Improved understanding of the complexities in diagnosing and managing cardiac conditions in geriatric populations.
- Enhanced awareness of the heightened risk of adverse drug events and interactions in elderly cardiac patients.
- Informed clinical practice regarding pharmacotherapy adjustments and monitoring for older adults with cardiovascular disease.
Abstract:
Cardiac insufficiency, coronary heart disease, and arrhythmia are not only more frequent in elderly patients, they are very often combined. By reason of cardiac morbidity and general morbidity as well as changed physiological and pathophysiological conditions, diagnosis of cardiac disease in elderly patients is more difficult. These conditions also apply to modifications in the therapy of cardiac diseases in advanced age. Especially pharmacodynamic and pharmacokinetic effects in advanced age combined with multimorbidity also account for the risk of interactions because of the simultaneous application of different pharmacological groups.